Seleen Ong is a Clinical Sciences Group Lead and subject matter expert for Clinical Trial Innovation at Pfizer. She manages a team of Clinical Scientists responsible for designing and delivering late phase clinical trials for Pfizer whilst also providing strategic leadership for Pfizer’s Clinical Trial Innovation initiatives. During her 12 years at Pfizer she also served as the European Digital Medicine Medical Director and held various positions in European Medical Affairs supporting Pfizer’s cardiovascular products. Seleen qualified in Medicine from King’s College London and attained her Membership of the Royal of College of Physicians (UK) in 2006 whilst working in the NHS, before joining Pfizer in 2007. She is a Fellow of the Faculty of Pharmaceutical Medicine in the UK.